| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/14/2005 | EP1572981A1 Mutations affecting plasmid copy number |
| 09/14/2005 | EP1572976A2 Modulating immune responses |
| 09/14/2005 | EP1572975A2 Streptococcus uberis adhesion molecule |
| 09/14/2005 | EP1572973A2 Mracs as modifiers of the rac pathway and methods of use |
| 09/14/2005 | EP1572971A2 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 09/14/2005 | EP1572970A2 Inhibitory oliogonucleotides targeted to bcl-2 |
| 09/14/2005 | EP1572968A2 Lutzomyia longipalpis polypeptides and methods of use |
| 09/14/2005 | EP1572967A2 Il-1 receptor based antagonists and methods of making and using |
| 09/14/2005 | EP1572966A2 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes and uses thereof |
| 09/14/2005 | EP1572964A2 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 09/14/2005 | EP1572962A2 Bioinformatically detectable group of novel regulatory genes and uses thereof |
| 09/14/2005 | EP1572959A2 Hybrid protein methods and compositions |
| 09/14/2005 | EP1572956A2 Methods and kits for synthesis of sirna expression cassettes |
| 09/14/2005 | EP1572953A2 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42 |
| 09/14/2005 | EP1572948A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/14/2005 | EP1572943A2 Circular nucleic acid vectors, and methods for making and using the same |
| 09/14/2005 | EP1572942A2 Live replicating spumavirus vector |
| 09/14/2005 | EP1572941A2 Novel flavivirus antigens |
| 09/14/2005 | EP1572940A2 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides |
| 09/14/2005 | EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 09/14/2005 | EP1572938A2 Polyvalent cation-sensing receptor in atlantic salmon |
| 09/14/2005 | EP1572937A2 Motif-grafted hybrid polypeptides and uses thereof |
| 09/14/2005 | EP1572935A2 Methods of making hypermutable cells using pmsr homologs |
| 09/14/2005 | EP1572934A2 Follistatin domain containing proteins |
| 09/14/2005 | EP1572933A2 Modulation of immune response by non-peptide binding stress response polypeptides |
| 09/14/2005 | EP1572932A2 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 09/14/2005 | EP1572930A2 Albumin-fused kunitz domain peptides |
| 09/14/2005 | EP1572929A2 Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes |
| 09/14/2005 | EP1572928A2 Plant acyl-coa synthetases |
| 09/14/2005 | EP1572927A2 Enhanced silk exsertion under stress |
| 09/14/2005 | EP1572923A2 Novel method for delivery and intracellular synthesis of sirna molecules |
| 09/14/2005 | EP1572922A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/14/2005 | EP1572921A2 Cytokine polypeptides |
| 09/14/2005 | EP1572919A2 Methods and compositions for use in homologous recombination |
| 09/14/2005 | EP1572917A2 Antibody gene transfer and recombinant aav therefor |
| 09/14/2005 | EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 09/14/2005 | EP1572914A2 Lambda integrase mediated recombination in plants |
| 09/14/2005 | EP1572913A2 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192 |
| 09/14/2005 | EP1572912A2 Selection free growth of host cells containing multiple integrating vectors |
| 09/14/2005 | EP1572911A2 Cloning of cytochrome p450 genes from nicotiana |
| 09/14/2005 | EP1572910A2 Signal for packaging of influenza virus vectors |
| 09/14/2005 | EP1572909A2 A follistatin domain containing protein |
| 09/14/2005 | EP1572908A2 Chimeric molecules for cleavage in a treated host |
| 09/14/2005 | EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same |
| 09/14/2005 | EP1572905A2 Cancer-linked gene as target for chemotherapy |
| 09/14/2005 | EP1572904A2 Modified bace |
| 09/14/2005 | EP1572903A2 Immunotherapeutics for biodefense |
| 09/14/2005 | EP1572902A2 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES |
| 09/14/2005 | EP1572901A2 Transposable elements in rice and methods of use |
| 09/14/2005 | EP1572900A2 Antibodies directed to pdgfd and uses thereof |
| 09/14/2005 | EP1572899A2 The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| 09/14/2005 | EP1572898A2 Novel proteins and nucleic acids encoding same |
| 09/14/2005 | EP1572895A2 Methods for producing hyaluronan in a recombinant host cell |
| 09/14/2005 | EP1572893A2 Production of adeno-associated virus in insect cells |
| 09/14/2005 | EP1572891A2 Bone anti-resorptive compounds |
| 09/14/2005 | EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use |
| 09/14/2005 | EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 09/14/2005 | EP1572888A2 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 09/14/2005 | EP1572887A2 Neural regeneration peptide and methods for their use in treatment of brain damage |
| 09/14/2005 | EP1572886A2 Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| 09/14/2005 | EP1572885A2 Methods for treating diabetes and other blood sugar disorders |
| 09/14/2005 | EP1572883A2 Human cytokine receptor |
| 09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
| 09/14/2005 | EP1572880A2 Defensin polynucleotides and methods of use |
| 09/14/2005 | EP1572878A2 Compositions and methods for inferring a response to a statin |
| 09/14/2005 | EP1572877A2 Drug metabolizing enzymes |
| 09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
| 09/14/2005 | EP1572875A2 Receptors and membrane-associated proteins |
| 09/14/2005 | EP1572872A2 Igs as modifiers of the p53 pathway and methods of use |
| 09/14/2005 | EP1572871A2 T1r3 a novel taste receptor |
| 09/14/2005 | EP1572870A2 Molecular sequence of pig endogenous retrovirus receptors and methods of use |
| 09/14/2005 | EP1572869A2 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof |
| 09/14/2005 | EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 09/14/2005 | EP1572867A2 Endothelial cell expression patterns |
| 09/14/2005 | EP1572866A2 Insect nuclear receptor genes and uses thereof |
| 09/14/2005 | EP1572864A2 Human serpin polypeptides |
| 09/14/2005 | EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/14/2005 | EP1572862A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 09/14/2005 | EP1572861A2 Ap1 amine oxidase variants |
| 09/14/2005 | EP1572860A2 Gradient structures interfacing microfluidics and nanofluidics, methods for fabrication and uses thereof |
| 09/14/2005 | EP1572748A1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 09/14/2005 | EP1572745A2 Antibody ("11c7") anti nogo a and its pharmaceutical use |
| 09/14/2005 | EP1572744A2 Immunoglobulin variants and uses thereof |
| 09/14/2005 | EP1572743A2 Peptides and their use for the treatment of hiv infections |
| 09/14/2005 | EP1572741A1 Therapeutic and diagnostic agents |
| 09/14/2005 | EP1572737A2 Midkine-like protein |
| 09/14/2005 | EP1572735A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 09/14/2005 | EP1572733A1 Inactive transcription factor tif-ia and uses thereof |
| 09/14/2005 | EP1572731A2 A method for the production of hiv-1 gag virus-like particles |
| 09/14/2005 | EP1572730A2 Nact as a target for lifespan expansion and weight reduction |
| 09/14/2005 | EP1572717A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/14/2005 | EP1572713A2 Antisense modulation of acyl-coa synthetase 1 expression |
| 09/14/2005 | EP1572679A2 Crfr1 selective ligands |
| 09/14/2005 | EP1572226A2 Peptides having a high cysteine content |
| 09/14/2005 | EP1572128A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/14/2005 | EP1572125A2 Compositions and methods for treating tumors bearing hmfg and cea antigens |
| 09/14/2005 | EP1572124A2 Hcv e1e2 vaccine compositions |
| 09/14/2005 | EP1572116A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2005 | EP1572111A2 Wound care compositions |
| 09/14/2005 | EP1572108A2 Functional mutations in respiratory syncytial virus |